维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Juozaityte"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer:a retrospective study of 574 patients 显示文摘	Inciura A Simavicius A Juozaityte E	2006	BMC Cancer2006，6，：	1
2	The influence of conformal radiotherapy on survival of lung cancer patients显示文摘	Norkus D Juozaityte E Inciura A	2003	Medicina(Kaunas)2003，39，3：	1
3	Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients显示文摘	Inciura A Simavicius A Juozaityte E	2006	BMC Cancer2006，8，6：	1
4	Phase III trial of liposom aldoxorub icin and cyclophospham id e compared with epirub icin and cyclophosph am ide as first line therapy for m etastatic breast cancer显示文摘	C han S Dav idsonN Juozaityte E	2004	Ann On cd2004，15，：	1
5	Phase Ⅲtrial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyelophosphamide as first-line therapy for metastatic breast cancer显示文摘	Chan S Davidson N Juozaityte E	2004	Ann Oncol2004，15，10：	1
6	Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer:a retrospective study of 574 patients显示文摘	Inciura A Simavicius A Juozaityte E		0，，：	1
7	Comparison of adjuvant and neoadjuvant chemotherapy in the manage- ment of advanced ovarian cancer : a retrospective study of 574 patients 显示文摘	Inciura A Simavicius A Juozaityte E	2006	BMC Cancer2006，8，6：	1
8	Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer:a retrospective study of 574 patients 显示文摘	INCIURA A SIMAVICIUS A JUOZAITYTE E	2006	BMC Cancer2006，8，6：	1
9	Impact of morphology and biology on the prognosis of patients with gliomas 显示文摘	GUDINAVICIENE 1 PRANYS D JUOZAITYTE E	2004	Medicina (Kaunas)2004，40，2：	1
10	Impact of dif- ferent treatment methods on survival in advanced pan- creatic cancer显示文摘	Brasiuniene B Juozaityte E Barauskas G	2005	Medicina (Kaunas)2005，41，5：	1
11	Comparison of adjuvant and neoadjuvant chemotherapy in the management of advanced ovarian cancer: a retrospective study of 574 patients 显示文摘	Ineiura A Simavieius A Juozaityte E	2006	BMC Cancer2006，6，：	1
12	Comparison of adjuvant and neoadjuvant chem- otherapy in themanagement of advanced ovari2 an cancer: a retrospective study of 574 patients 显示文摘	Inciura A Simavicius A Juozaityte E	2006	BMC Cancer2006，8，6：	1
13	Long-term results of high-dose-rate brachytherapy and external- beam radiotherapy in the primary treatment of endome trialcancer显示文摘	Inciura A Atkocius V Juozaityte E	2010	JRadiatRes2010，51，6：	1
14	A single gene target of an ETS-family transcription factor determines neuronal CO2-chemosensitivity显示文摘	Brandt J P Aziz-Zaman S Juozaityte V Martinez-Velazquez L A Petersen J G Pocock R Ringstad N		0，，：	1
15	Phase Ⅲ trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer 显示文摘	Chan S Davidson N Juozaityte E	2004	Ann Oncd2004，15，：	1
16	Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy显示文摘	Rudzianskas V Inciura A Juozaityte E	2012	Acta Otorhinolaryngol Ital2012，32，5：	1
17	Safety and efficacy study of the recombinant granulocyte colony-stimulating factor for prevention of neutropenia and neutropenia-related complications in women with meta-static breast cancer receiving docetaxel/doxorubicin显示文摘	Liutkauskiene S Sveikata A Juozaityte E	2009	Medicine(Kau-nas)2009，45，8：	1
18	Comparison of Implant Quality between Loose and Intra-operatively Linked Iodine-125 Seeds in Prostate Cancer Brachytherapy显示文摘	Jarusevicius L Inciura A Juozaityte E		0，，03：	1
19	Multi- ple endocrine neoplasia syndroms Type 1 显示文摘	JUODELE L JUOZAITYTE E ZINDZIUS A	2004	Medicina ( Kaunas )2004，40，5：	1
20	Reirradiation of recurrent head and neck cancer using high-dose-rate brachytherapy 显示文摘	Rudzianskas V Inciura A Juozaityte E	2012	Acta Otorhinolaryngol Ital2012，32，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示